Search results
Results from the WOW.Com Content Network
WuXi Biologics is a global Contract Research Development and Manufacturing Organization (CRDMO) that provides open-access, integrated technology platforms for biologics drug development. WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and good ...
A WuXi Biologics spokesperson said the vote and disssenting voices reflect an improved understanding among key legislators of the company's role in the industry and its U.S. operations.
WuXi PharmaTech was founded in December 2000 in Shanghai by organic chemist Ge Li. [1] [2]The company opened chemistry facilities in Tianjin in 2007. In 2008, WuXi PharmaTech acquired AppTec Laboratory Services Inc., a US-based company founded in 2001 with expertise in medical-device and biologics testing and with facilities in St. Paul, MN; Philadelphia, PA; and Atlanta, GA.
The latest Biosecure Act also adds WuXi Biologics to a list of biotech companies of concern, according to a copy seen by Reuters. ... USA TODAY 'Overjoyed': Oregon man revealed as winner of $328 ...
Shares of WuXi AppTec and WuXi Biologics tumbled on Friday as investor fears grew over the draft legislation targeting the China biotech giants. WuXi AppTec, which provides drug R&D and ...
Biotech and pharmaceutical companies in the New York metropolitan area represent a significant and growing economic component of the New York metropolitan area, [1] [2] the most populous combined statistical area in the United States [3] and one of the most populous megacities in the world.
In 2023, Wuxi Biologics earned about 47% of its 17 billion yuan ($2.35 billion) in annual sales from North America and about 18% from China, according to its annual report.
In 2016, WuXi AppTec expanded its presence in the United States by opening a new center of excellence in San Diego, California. [10] This facility was designed to enhance WuXi's capabilities in small molecule screening, discovery biology, and process research and development, while also offering Phase I Good manufacturing practice (GMP) services.